Correlation Between Aadi Bioscience and Allovir

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aadi Bioscience and Allovir at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aadi Bioscience and Allovir into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aadi Bioscience and Allovir, you can compare the effects of market volatilities on Aadi Bioscience and Allovir and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aadi Bioscience with a short position of Allovir. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aadi Bioscience and Allovir.

Diversification Opportunities for Aadi Bioscience and Allovir

-0.74
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Aadi and Allovir is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Aadi Bioscience and Allovir in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allovir and Aadi Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aadi Bioscience are associated (or correlated) with Allovir. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allovir has no effect on the direction of Aadi Bioscience i.e., Aadi Bioscience and Allovir go up and down completely randomly.

Pair Corralation between Aadi Bioscience and Allovir

Given the investment horizon of 90 days Aadi Bioscience is expected to generate 0.6 times more return on investment than Allovir. However, Aadi Bioscience is 1.66 times less risky than Allovir. It trades about 0.21 of its potential returns per unit of risk. Allovir is currently generating about -0.16 per unit of risk. If you would invest  217.00  in Aadi Bioscience on September 13, 2024 and sell it today you would earn a total of  24.00  from holding Aadi Bioscience or generate 11.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Aadi Bioscience  vs.  Allovir

 Performance 
       Timeline  
Aadi Bioscience 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Aadi Bioscience are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak fundamental indicators, Aadi Bioscience demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Allovir 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Allovir has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Aadi Bioscience and Allovir Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aadi Bioscience and Allovir

The main advantage of trading using opposite Aadi Bioscience and Allovir positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aadi Bioscience position performs unexpectedly, Allovir can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will offset losses from the drop in Allovir's long position.
The idea behind Aadi Bioscience and Allovir pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios